Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice
Pulmonary fibrosis is the most frequent form of interstitial lung disease. Effective therapies are not yet available; novel therapeutic approaches are needed for counteracting fibrosis. Poly(ADP-ribose) polymerases are enzymes, involved in DNA repair and cell apoptosis. PARP-1 deficient mice exhibit...
Saved in:
Main Authors: | Mariaconcetta Durante (Author), Silvia Sgambellone (Author), Cecilia Lanzi (Author), Patrizia Nardini (Author), Alessandro Pini (Author), Flavio Moroni (Author), Emanuela Masini (Author), Laura Lucarini (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia
by: Ilaria Dettori, et al.
Published: (2018) -
Stimulation of Histamine H1 Receptor Up-Regulates Histamine H1 Receptor Itself Through Activation of Receptor Gene Transcription
by: Asish K. Das, et al.
Published: (2007) -
Molecular Cloning of Monkey Histamine H4 Receptor
by: Tamaki Oda, et al.
Published: (2005) -
The Histamine H4 Receptor: From Orphan to the Clinic
by: Robin L. Thurmond
Published: (2015) -
A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers
by: Tingting Du, et al.
Published: (2022)